Bharat Biotech’s Covaxin
Covaxin, manufactured by the Hyderabad-based pharma major Bharat Biotech, will be available in Bahrain for people aged 18 years and above after the approval.
"We are pleased to announce our EUA filing to the US-Food and Drug Administration (FDA) through our partners- Ocugen," tweeted Dr Raches Ella, Bharat Biotech's clinical lead for Covid-19 vaccines.
The Australian regulatory authority for therapeutic goods ‘Therapeutic Goods Administration’ (TGA), Department of Health released a notice recognising Covaxin for the purpose of establishing a traveller’s vaccination status.
United Nations/Geneva: A decision on Bharat Biotech's submission seeking emergency use listing (EUL) for its Covaxin COVID-19 vaccine will be made in October, the...
Several research activities are being carried out to study Variants of Concern and assess their suitability for follow-up booster doses, the company said here on Tuesday.
Covaxin does not contain newborn calf serum at all and the calf serum is not an ingredient of the final vaccine
In the EOI, the Directorate General of Health Services (DGHS) stated that the offered vaccine must be duly approved by a competent authority of the government of India.
A modest reduction in neutralisation by a factor of 1.95 was observed against B1617 variant compared to vaccine variant.
"The agreement with Precisa Medicamentos is based on a long term partnership and will continue,” Bharat Biotech stated.
The Covid-19 vaccines - Covaxin and Covishield, will be made available to the general public from today.
Krishnamma, a sanitation worker at Gandhi Hospital was the first person to receive the Covid vaccine in Telangana.
- Advertisement -